Asset profile
Dexamethasone
Unknown / undisclosed
Approved / Phase 4Mechanism not established
Approvedregulatory verdict
Evidence outlook
Approved: Ocular Inflammation and Pain
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
Featured evidence outside covered markets:NCT00002548 · Multiple Myeloma · Phase 3 · completed · ungradedNCT00002678 · Multiple Myeloma and Plasma Cell Neoplasm · Phase 3 · completed · ungraded
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
(159 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (21)
October 2026 (5)
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2026-10-12 · NCT05372354 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple MyelomaRecruiting
Est. primary completion 2026-10-20 · NCT06140966 · CT.gov ↗
What to watch
Phase 1Non-Hodgkin LymphomaActive not recruiting
Est. primary completion 2026-10-31 · NCT05688475 · CT.gov ↗
What to watch
Phase 1/2Multiple Myeloma, Multiple Myeloma in Relapse, Neoplasms, Gammopathy, Monoclonal, Paraproteinemias, Blood Protein Disorders …Not yet recruiting
Est. primary completion 2026-10-31 · NCT05581875 · CT.gov ↗
What to watch
Phase 1/2Multiple Myeloma, Neoplasms, Neoplasm, Plasma Cell, Gammopathy, Monoclonal, Paraproteinemias, Blood Protein Disorders …Recruiting
Est. primary completion 2026-10-31 · NCT05573802 · CT.gov ↗
What to watch
November 2026 (5)
Phase 1Multiple MyelomaActive not recruiting
Est. primary completion 2026-11 · NCT05560399 · CT.gov ↗
What to watch
Phase 1/2Relapsed/Refractory Multiple MyelomaRecruiting
Est. primary completion 2026-11 · NCT04973605 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2026-11 · NCT06505369 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma, Plasma Cell LeukemiaRecruiting
Est. primary completion 2026-11 · NCT06517017 · CT.gov ↗
What to watch
Phase 1/2Multiple MyelomaActive not recruiting
Est. primary completion 2026-11-30 · NCT03989414 · CT.gov ↗
What to watch
December 2026 (11)
Phase 1Radiotracer, Hypertension, CholesterolRecruiting
Est. primary completion 2026-12 · NCT04546126 · CT.gov ↗
What to watch
Phase 1Multiple MyelomaActive not recruiting
Est. primary completion 2026-12 · NCT01562405 · CT.gov ↗
What to watch
Phase 2Myeloma, MultipleActive not recruiting
Est. primary completion 2026-12 · NCT04009109 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2026-12 · NCT02718833 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2026-12-28 · NCT03729804 · CT.gov ↗
What to watch
Phase 1Recurrent Multiple Myeloma, Refractory Multiple MyelomaActive not recruiting
Est. primary completion 2026-12-31 · NCT05981209 · CT.gov ↗
What to watch
Phase 1/2Recurrent Plasma Cell Myeloma, Refractory Plasma Cell MyelomaActive not recruiting
Est. primary completion 2026-12-31 · NCT05514990 · CT.gov ↗
What to watch
Phase 2Recurrent Multiple Myeloma, Refractory Multiple MyelomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04883242 · CT.gov ↗
What to watch
Phase 3Plasma Cell MyelomaActive not recruiting
Est. primary completion 2026-12-31 · NCT01863550 · CT.gov ↗
What to watch
Early phase / not applicableMultiple Myeloma, NeoplasmsActive not recruiting
Est. primary completion 2026-12-31 · NCT06924424 · CT.gov ↗
What to watch
2027 (66)
January 2027 (5)
Early phase / not applicableHip OsteoarthritisRecruiting
Est. primary completion 2027-01-01 · NCT07330999 · CT.gov ↗
What to watch
Early phase / not applicableKnee OsteoarthritisRecruiting
Est. primary completion 2027-01-01 · NCT07386600 · CT.gov ↗
What to watch
Phase 4Multiple MyelomaActive not recruiting
Est. primary completion 2027-01-03 · NCT03829371 · CT.gov ↗
What to watch
Phase 2Plasma Cell Myeloma RefractoryRecruiting
Est. primary completion 2027-01-08 · NCT06356571 · CT.gov ↗
What to watch
Phase 3Relapsed or Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-01-10 · NCT05519085 · CT.gov ↗
What to watch
February 2027 (4)
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-02-01 · NCT04268498 · CT.gov ↗
What to watch
Phase 2Sickle Cell Disease, Thalassemia, Beta, ThalassemiaRecruiting
Est. primary completion 2027-02-09 · NCT05736419 · CT.gov ↗
What to watch
Phase 2Recurrent Plasma Cell Myeloma, Refractory Plasma Cell MyelomaRecruiting
Est. primary completion 2027-02-14 · NCT04508790 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-02-26 · NCT04133636 · CT.gov ↗
What to watch
March 2027 (3)
Phase 2Multiple Myeloma, Extramedullary PlasmacytomaActive not recruiting
Est. primary completion 2027-03 · NCT04166565 · CT.gov ↗
What to watch
Phase 1/2Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma, Higher-risk Myelodysplastic Syndrome …Recruiting
Est. primary completion 2027-03-31 · NCT04068597 · CT.gov ↗
What to watch
Phase 3Relapsed/Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-03-31 · NCT06508983 · CT.gov ↗
What to watch
April 2027 (5)
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2027-04 · NCT02343042 · CT.gov ↗
What to watch
Phase 3Newly Diagnosed Multiple MyelomaRecruiting
Est. primary completion 2027-04 · NCT05558319 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-04-01 · NCT04835129 · CT.gov ↗
What to watch
Phase 3Plasma Cell MyelomaActive not recruiting
Est. primary completion 2027-04-05 · NCT03319667 · CT.gov ↗
What to watch
Phase 1Recurrent Multiple Myeloma, Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-04-10 · NCT06622005 · CT.gov ↗
What to watch
May 2027 (4)
Phase 2Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse, RelapseActive not recruiting
Est. primary completion 2027-05 · NCT04176718 · CT.gov ↗
What to watch
Phase 2Extramedullary Disease in Multiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-05-01 · NCT06627751 · CT.gov ↗
What to watch
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2027-05-31 · NCT06988488 · CT.gov ↗
What to watch
Phase 2Breast Neoplasms, Lung NeoplasmsRecruiting
Est. primary completion 2027-05-31 · NCT06974604 · CT.gov ↗
What to watch
June 2027 (3)
Phase 1/2Multiple MyelomaActive not recruiting
Est. primary completion 2027-06 · NCT01297764 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-06 · NCT02899052 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma in Relapse, Multiple Myeloma, RefractoryNot yet recruiting
Est. primary completion 2027-06-30 · NCT05909826 · CT.gov ↗
What to watch
July 2027 (6)
Phase 1/2Relapse Multiple Myeloma, Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-07 · NCT07479979 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-07 · NCT03556332 · CT.gov ↗
What to watch
Phase 1Relapsed Refractory Multiple Myeloma (RRMM)Recruiting
Est. primary completion 2027-07-01 · NCT07032714 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma, Deletion 17P SyndromeActive not recruiting
Est. primary completion 2027-07-01 · NCT04124497 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2027-07-30 · NCT05455320 · CT.gov ↗
What to watch
Phase 1Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple MyelomaRecruiting
Est. primary completion 2027-07-31 · NCT06348108 · CT.gov ↗
What to watch
August 2027 (5)
Phase 1Multiple MyelomaRecruiting
Est. primary completion 2027-08 · NCT03909412 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2027-08 · NCT05972135 · CT.gov ↗
What to watch
Phase 2/3Newly Diagnosed Multiple MyelomaRecruiting
Est. primary completion 2027-08 · NCT05665140 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2027-08 · NCT00572169 · CT.gov ↗
What to watch
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2027-08-16 · NCT06106945 · CT.gov ↗
What to watch
September 2027 (5)
Phase 3Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene MutationRecruiting
Est. primary completion 2027-09 · NCT06382948 · CT.gov ↗
What to watch
Phase 2Smoldering Plasma Cell MyelomaRecruiting
Est. primary completion 2027-09-01 · NCT04776395 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma in Relapse, Refractory Multiple MyelomaActive not recruiting
Est. primary completion 2027-09-01 · NCT04790474 · CT.gov ↗
What to watch
Phase 3Multiple Myeloma, New Diagnosis TumorActive not recruiting
Est. primary completion 2027-09-01 · NCT04096066 · CT.gov ↗
What to watch
Phase 1/2Plasma Cell Myeloma RefractoryRecruiting
Est. primary completion 2027-09-13 · NCT04643002 · CT.gov ↗
What to watch
October 2027 (5)
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-10 · NCT00869232 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-10 · NCT03004287 · CT.gov ↗
What to watch
Phase 4Preeclampsia, Spinal Anesthesia-Induced Hypotension, Cesarean SectionNot yet recruiting
Est. primary completion 2027-10 · NCT07793760 · CT.gov ↗
What to watch
Phase 2Plasma Cell MyelomaRecruiting
Est. primary completion 2027-10-21 · NCT05208307 · CT.gov ↗
What to watch
Phase 2Recurrent Plasma Cell Myeloma, Refractory Plasma Cell MyelomaActive not recruiting
Est. primary completion 2027-10-30 · NCT03763162 · CT.gov ↗
What to watch
November 2027 (6)
Phase 2Relapsed or Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-11 · NCT07018050 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2027-11 · NCT02659293 · CT.gov ↗
What to watch
Phase 1Multiple Myeloma, Renal FailureRecruiting
Est. primary completion 2027-11-01 · NCT06142396 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2027-11-16 · NCT04975997 · CT.gov ↗
What to watch
Phase 1/2Multiple Myeloma RefractoryRecruiting
Est. primary completion 2027-11-30 · NCT07210047 · CT.gov ↗
What to watch
Phase 4Newly Diagnosed, High Risk, MRD, Multiple MyelomaRecruiting
Est. primary completion 2027-11-30 · NCT06409702 · CT.gov ↗
What to watch
December 2027 (15)
Phase 2MyelomaActive not recruiting
Est. primary completion 2027-12 · NCT00871013 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-12 · NCT04392037 · CT.gov ↗
What to watch
Phase 2Newly Diagnosed Multiple MyelomaActive not recruiting
Est. primary completion 2027-12 · NCT04891809 · CT.gov ↗
What to watch
Phase 3Relapsed or Refractory Multiple MyelomaRecruiting
Est. primary completion 2027-12 · NCT07138209 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaNot yet recruiting
Est. primary completion 2027-12 · NCT06742138 · CT.gov ↗
What to watch
Phase 3Multiple Myeloma (MM)Recruiting
Est. primary completion 2027-12 · NCT07297329 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2027-12 · NCT06158841 · CT.gov ↗
What to watch
Phase 2High-risk Smoldering Multiple Myeloma, Multiple MyelomaActive not recruiting
Est. primary completion 2027-12-20 · NCT04775550 · CT.gov ↗
What to watch
Phase 3Relapsed or Refractory Multiple Myeloma (RRMM)Recruiting
Est. primary completion 2027-12-30 · NCT06615479 · CT.gov ↗
What to watch
Phase 1/2Cystoid Macular EdemaRecruiting
Est. primary completion 2027-12-31 · NCT04225611 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-12-31 · NCT03376672 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma (MM)Not yet recruiting
Est. primary completion 2027-12-31 · NCT07811986 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Intrahepatic Bile Duct Cancer, Colorectal Neoplasms …Recruiting
Est. primary completion 2027-12-31 · NCT05286814 · CT.gov ↗
What to watch
Phase 3Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell MyelomaRecruiting
Est. primary completion 2027-12-31 · NCT04566328 · CT.gov ↗
What to watch
2028 (24)
January 2028 (1)
Phase 2Multiple Myeloma, RefractoryRecruiting
Est. primary completion 2028-01 · NCT04414475 · CT.gov ↗
What to watch
February 2028 (1)
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2028-02 · NCT04661137 · CT.gov ↗
What to watch
March 2028 (4)
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2028-03 · NCT05272826 · CT.gov ↗
What to watch
Phase 2/3Multiple Myeloma, Newly DiagnosedRecruiting
Est. primary completion 2028-03 · NCT06879379 · CT.gov ↗
What to watch
Phase 2Relapsed and Refractory Multiple MyelomaRecruiting
Est. primary completion 2028-03-26 · NCT05530421 · CT.gov ↗
What to watch
Phase 1Multiple Myeloma, Triple Negative Breast Cancer, Duffy Blood Group, Chemokine Receptor Gene Mutation, Duffy Blood Group …Recruiting
Est. primary completion 2028-03-31 · NCT07341867 · CT.gov ↗
What to watch
April 2028 (1)
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2028-04-26 · NCT06353022 · CT.gov ↗
What to watch
June 2028 (2)
July 2028 (2)
August 2028 (4)
Phase 1/2Multiple MyelomaActive not recruiting
Est. primary completion 2028-08 · NCT05434689 · CT.gov ↗
What to watch
Phase 1Multiple MyelomaRecruiting
Est. primary completion 2028-08-01 · NCT06121843 · CT.gov ↗
What to watch
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2028-08-03 · NCT05714839 · CT.gov ↗
What to watch
Phase 2Asthma (Diagnosis)Recruiting
Est. primary completion 2028-08-14 · NCT07455396 · CT.gov ↗
What to watch
September 2028 (1)
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2028-09-15 · NCT05695508 · CT.gov ↗
What to watch
October 2028 (1)
Phase 3Multiple MyelomaRecruiting
Est. primary completion 2028-10-31 · NCT07555938 · CT.gov ↗
What to watch
November 2028 (2)
December 2028 (5)
Phase 3Multiple Myeloma, Relapse Multiple MyelomaRecruiting
Est. primary completion 2028-12 · NCT06561854 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2028-12 · NCT06216158 · CT.gov ↗
What to watch
Phase 1Multiple MyelomaRecruiting
Est. primary completion 2028-12-21 · NCT04910568 · CT.gov ↗
What to watch
Phase 2Relapsed Cancer, Refractory Multiple Myeloma, Multiple MyelomaRecruiting
Est. primary completion 2028-12-31 · NCT05922501 · CT.gov ↗
What to watch
Phase 4Newly Diagnosed Multiple Myeloma, T(11;14), Sotoclax, CarfilzomibNot yet recruiting
Est. primary completion 2028-12-31 · NCT07709884 · CT.gov ↗
What to watch
2029 (18)
January 2029 (3)
Phase 2Myeloma MultipleRecruiting
Est. primary completion 2029-01-11 · NCT07085728 · CT.gov ↗
What to watch
Phase 3Newly Diagnosed Multiple MyelomaRecruiting
Est. primary completion 2029-01-11 · NCT07764978 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2029-01-31 · NCT05438043 · CT.gov ↗
What to watch
February 2029 (3)
Phase 2Relapsed or Refractory Multiple Myeloma (RRMM)Not yet recruiting
Est. primary completion 2029-02 · NCT07348393 · CT.gov ↗
What to watch
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2029-02-14 · NCT04923893 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaNot yet recruiting
Est. primary completion 2029-02-28 · NCT07614360 · CT.gov ↗
What to watch
March 2029 (1)
Phase 2Refractory Multiple Myeloma, Relapsed Multiple MyelomaRecruiting
Est. primary completion 2029-03-01 · NCT05896228 · CT.gov ↗
What to watch
April 2029 (2)
May 2029 (1)
Phase 3Relapsed and/or Refractory Multiple Myeloma (RRMM)Recruiting
Est. primary completion 2029-05-21 · NCT07222761 · CT.gov ↗
What to watch
July 2029 (1)
Phase 1Type 2 Diabetes, Chronic Kidney DiseasesActive not recruiting
Est. primary completion 2029-07-31 · NCT06190158 · CT.gov ↗
What to watch
August 2029 (1)
Phase 3Newly Diagnosed Multiple MyelomaActive not recruiting
Est. primary completion 2029-08 · NCT03948035 · CT.gov ↗
What to watch
November 2029 (1)
Phase 3Multiple Myeloma Refractory, Multiple Myeloma in RelapseRecruiting
Est. primary completion 2029-11 · NCT07772024 · CT.gov ↗
What to watch
December 2029 (5)
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2029-12 · NCT05527340 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2029-12-01 · NCT04240054 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma Refractory, Multiple Myeloma in RelapseRecruiting
Est. primary completion 2029-12-01 · NCT07096778 · CT.gov ↗
What to watch
Phase 1/2Myeloma, Multiple Myeloma, Refractory Multiple MyelomaRecruiting
Est. primary completion 2029-12-31 · NCT06518551 · CT.gov ↗
What to watch
Phase 3Smoldering Plasma Cell MyelomaRecruiting
Est. primary completion 2029-12-31 · NCT03937635 · CT.gov ↗
What to watch
2030 (9)
January 2030 (1)
Phase 2Multiple Myeloma at First RelapseActive not recruiting
Est. primary completion 2030-01-01 · NCT04998786 · CT.gov ↗
What to watch
March 2030 (1)
Phase 2Multiple Myeloma, Relapsed/Refractory Multiple MyelomaRecruiting
Est. primary completion 2030-03 · NCT07284758 · CT.gov ↗
What to watch
August 2030 (1)
Phase 2Multiple MyelomaRecruiting
Est. primary completion 2030-08-30 · NCT07227311 · CT.gov ↗
What to watch
September 2030 (2)
October 2030 (1)
Phase 3Plasma Cell MyelomaActive not recruiting
Est. primary completion 2030-10-14 · NCT04270409 · CT.gov ↗
What to watch
December 2030 (3)
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2030-12 · NCT06953960 · CT.gov ↗
What to watch
Phase 2Multiple Myeloma, Newly Diagnosed Multiple Myeloma, Transplant Ineligible, Newly Diagnosed Multiple Myeloma (NDMM)Not yet recruiting
Est. primary completion 2030-12-01 · NCT07247097 · CT.gov ↗
What to watch
Phase 3Breast Cancer, Interstitial Lung Disease (ILD)Not yet recruiting
Est. primary completion 2030-12-20 · NCT07828054 · CT.gov ↗
What to watch
2031 (8)
January 2031 (1)
Phase 3Multiple MyelomaRecruiting
Est. primary completion 2031-01 · NCT06187441 · CT.gov ↗
What to watch
April 2031 (2)
May 2031 (2)
June 2031 (1)
Phase 2/3Multiple MyelomaRecruiting
Est. primary completion 2031-06-01 · NCT04513639 · CT.gov ↗
What to watch
August 2031 (1)
Phase 1Multiple MyelomaNot yet recruiting
Est. primary completion 2031-08-22 · NCT07609706 · CT.gov ↗
What to watch
November 2031 (1)
Phase 3Multiple MyelomaRecruiting
Est. primary completion 2031-11 · NCT07285239 · CT.gov ↗
What to watch
2032 (3)
January 2032 (1)
Phase 3Multiple MyelomaRecruiting
Est. primary completion 2032-01-31 · NCT06182774 · CT.gov ↗
What to watch
2033 (5)
March 2033 (1)
Phase 2Relapsed / Refractory Multiple MyelomaNot yet recruiting
Est. primary completion 2033-03 · NCT07748689 · CT.gov ↗
What to watch
May 2033 (1)
Phase 2Multiple Myeloma, CancerRecruiting
Est. primary completion 2033-05-28 · NCT05145400 · CT.gov ↗
What to watch
June 2033 (1)
Phase 3Multiple MyelomaActive not recruiting
Est. primary completion 2033-06 · NCT05257083 · CT.gov ↗
What to watch
September 2033 (1)
Phase 1Relapsed/Refractory Multiple MyelomaActive not recruiting
Est. primary completion 2033-09 · NCT05259839 · CT.gov ↗
What to watch
October 2033 (1)
Phase 3Multiple MyelomaNot yet recruiting
Est. primary completion 2033-10-01 · NCT07624513 · CT.gov ↗
What to watch
2035 (1)
December 2035 (1)
Phase 1/2Multiple MyelomaRecruiting
Est. primary completion 2035-12 · NCT06892522 · CT.gov ↗
What to watch
2036 (3)
May 2036 (1)
Phase 3Multiple Myeloma, Newly DiagnosedRecruiting
Est. primary completion 2036-05 · NCT06918002 · CT.gov ↗
What to watch
September 2036 (1)
Phase 1/2Myeloma Multiple, MyelomaNot yet recruiting
Est. primary completion 2036-09-30 · NCT07600151 · CT.gov ↗
What to watch
December 2036 (1)
Phase 3Multiple MyelomaRecruiting
Est. primary completion 2036-12 · NCT06932562 · CT.gov ↗
What to watch
2040 (1)
September 2040 (1)
Phase 2/3Multiple MyelomaRecruiting
Est. primary completion 2040-09 · NCT07095452 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.